Progress report of a Phase I study of the intracerebral microinfusion of a recombinant chimeric protein composed of transforming growth factor (TGF)-alpha and a mutated form of the Pseudomonas exotoxin termed PE-38 (TP-38) for the treatment of malig
scientific article published in October 2003
Author/s
author: Henry Seth Friedman, Darell D. Bigner, Allan Friedman, David A Reardon, Roger E McLendon, Jeremy N Rich, Jennifer J Quinn, James H. Herndon, Mitchel S. Berger, James M Provenzale, Sandra Tourt-Uhlig, Kara L Penne, Michael R Zalutsky, Gamal Akabani, Alison Paolino, Carol J Wikstrand, Sandeep Kunwar, Timothy T Stenzel, Ira Pastan
Work details
Copyright status
Copyright status information is not available for this work. The copyright status depends on the jurisdiction, the author's date of death and the date the work was created or published.
To learn more about copyright terms in different countries, visit the countries and terms page.